Tempus AI, Inc.
TEM Healthcare Health Information Services
Tempus AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 83.4% from fiscal 2024. In the quarter to June 2026, revenue grew 21.6%, EPS grew 112.0%, free cash flow fell 153.7% and total debt rose 70.5%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for three.
Follow TEM
Tempus AI, Inc. (TEM) EV/Sales
As of 16 October 2026, Tempus AI, Inc. (TEM) trades at a EV/Sales of 8.5×. Over the past ten years it has ranged from 3.4× (June 2024) to 20.0× (November 2024); the current reading is higher than 42% of that period. That is above the Health Information Services industry median of 2.6× and above the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 8.5× | 45.65% |
| FY2024 | 5.8× | 12.57% |
| FY2023 | 5.2× | 0.00% |
| FY2022 | 5.2× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 7.7× | 20.32% |
| Mar 2026 | 6.4× | (24.87%) |
| Dec 2025 | 8.5× | (35.89%) |
| Sep 2025 | 13.2× | 9.17% |
| 10 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| BTSG BrightSpring Health Services, Inc. compare | 1.0× |
| WAY Waystar Holding Corp. compare | 5.4× |
| HQY HealthEquity, Inc. compare | 6.1× |
| DOCS Doximity, Inc. compare | 7.6× |
| TEM Tempus AI, Inc. | 8.5× |
| HNGE Hinge Health Inc. compare | 10.3× |
| VEEV Veeva Systems Inc. compare | 12.5× |
| TXG 10x Genomics compare | 13.9× |
| HTFL Heartflow, Inc. compare | 19.8× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)